PMID: 2484693Jan 1, 1989Paper

Molsidomine and lipid metabolism

Journal of Cardiovascular Pharmacology
G Chassoux

Abstract

A postmarketing surveillance study was carried out in 3,757 patients suffering from chronic stable angina pectoris or angina at rest and treated with molsidomine alone or in combination with other antianginal drugs. During the 12-month survey, there was a significant decrease of total cholesterol, triglycerides, apolipoprotein B and B/A1 ratio, but no change of apolipoprotein A1. These results indicate that further investigations should be undertaken to analyze the possible favorable effect of molsidomine on lipid metabolism.

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
I D WilsonE Schraven
Proceedings of the National Academy of Sciences of the United States of America
J RineR W Davis
Blood Vessels
J Reden
© 2022 Meta ULC. All rights reserved